RadNet (RDNT) Competitors

$57.45
-0.13 (-0.23%)
(As of 05/17/2024 ET)

RDNT vs. FTRE, GH, VCYT, CSTL, FLGT, CDNA, BDSX, BNR, PSNL, and RNLX

Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fortrea (FTRE), Guardant Health (GH), Veracyte (VCYT), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), CareDx (CDNA), Biodesix (BDSX), Burning Rock Biotech (BNR), Personalis (PSNL), and Renalytix (RNLX). These companies are all part of the "medical laboratories" industry.

RadNet vs.

Fortrea (NASDAQ:FTRE) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, community ranking, earnings, media sentiment and risk.

RadNet has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortrea$3.11B0.79-$3.40M-$1.39-19.82
RadNet$1.62B2.63$3.04M$0.30191.50

Fortrea presently has a consensus target price of $35.57, indicating a potential upside of 29.12%. RadNet has a consensus target price of $57.25, indicating a potential downside of 0.35%. Given RadNet's higher probable upside, equities analysts clearly believe Fortrea is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortrea
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.67
RadNet
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

RadNet has a net margin of 1.28% compared to RadNet's net margin of -4.11%. Fortrea's return on equity of 5.05% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Fortrea-4.11% 4.76% 1.87%
RadNet 1.28%5.05%1.57%

77.9% of RadNet shares are owned by institutional investors. 0.1% of Fortrea shares are owned by company insiders. Comparatively, 4.4% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Fortrea had 24 more articles in the media than RadNet. MarketBeat recorded 35 mentions for Fortrea and 11 mentions for RadNet. Fortrea's average media sentiment score of 0.42 beat RadNet's score of 0.38 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortrea
9 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
7 Negative mention(s)
1 Very Negative mention(s)
Neutral
RadNet
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

RadNet received 333 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.70% of users gave RadNet an outperform vote while only 47.06% of users gave Fortrea an outperform vote.

CompanyUnderperformOutperform
FortreaOutperform Votes
8
47.06%
Underperform Votes
9
52.94%
RadNetOutperform Votes
341
65.70%
Underperform Votes
178
34.30%

Summary

RadNet beats Fortrea on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RDNT vs. The Competition

MetricRadNetMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$4.24B$2.34B$5.17B$7.96B
Dividend YieldN/A1.80%44.01%3.91%
P/E Ratio191.5012.74118.4515.56
Price / Sales2.63129.102,367.4177.86
Price / Cash17.28375.1736.4531.98
Price / Book3.943.795.754.76
Net Income$3.04M-$135.88M$105.79M$217.17M
7 Day Performance3.98%0.66%1.39%2.90%
1 Month Performance20.67%6.75%4.28%6.57%
1 Year Performance104.30%-5.46%7.71%10.17%

RadNet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTRE
Fortrea
2.9954 of 5 stars
$36.47
+0.4%
$37.29
+2.2%
N/A$3.26B$3.11B0.0018,000Earnings Report
Analyst Upgrade
News Coverage
GH
Guardant Health
4.6581 of 5 stars
$18.82
-1.5%
$37.70
+100.3%
-12.7%$2.29B$563.95M-4.401,779Short Interest ↑
VCYT
Veracyte
2.8189 of 5 stars
$21.03
+0.5%
$29.00
+37.9%
-8.7%$1.61B$361.05M-20.42815Positive News
CSTL
Castle Biosciences
1.4831 of 5 stars
$23.80
-2.5%
$31.57
+32.7%
+5.9%$656.98M$219.79M-20.69610
FLGT
Fulgent Genetics
4.0654 of 5 stars
$21.32
-0.8%
$30.00
+40.7%
-38.0%$637.47M$289.21M-3.831,184Short Interest ↑
CDNA
CareDx
2.5543 of 5 stars
$10.48
+2.9%
$14.00
+33.6%
+99.5%$542.65M$280.32M-2.96635Analyst Forecast
Short Interest ↑
News Coverage
BDSX
Biodesix
2.9409 of 5 stars
$1.55
+2.0%
$3.25
+109.7%
+30.2%$177.77M$49.09M-2.38217Short Interest ↑
BNR
Burning Rock Biotech
0 of 5 stars
$0.83
+2.5%
N/A-70.3%$85.09M$75.70M-0.931,138Stock Split
News Coverage
PSNL
Personalis
4.4581 of 5 stars
$1.58
-0.6%
$5.00
+216.5%
-32.4%$79.79M$73.48M-0.70223Positive News
Gap Down
RNLX
Renalytix
1.8271 of 5 stars
$0.69
flat
$5.00
+623.1%
-75.3%$53.37M$3.40M-1.54102

Related Companies and Tools

This page (NASDAQ:RDNT) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners